Stamaril

Stamaril is a live, attenuated yellow fever vaccine derived from the 17D-204 strain, designed to provide immunity against yellow fever virus. This vaccine is administered via injection and is widely used for travel health protection. Store in a cool, dry place away from direct sunlight.

Stamaril is used to prevent yellow fever, a viral infection spread by infected mosquitoes. It is recommended for travelers visiting regions where yellow fever is endemic or for those requiring proof of vaccination for entry. The vaccine stimulates the immune system to produce antibodies against the virus. It is also used for individuals at risk of exposure due to occupational hazards.

After administration, Stamaril may cause mild reactions such as soreness at the injection site, low-grade fever, or headache. Some individuals may experience fatigue or muscle aches. These effects are generally temporary and resolve within a few days. Serious reactions are rare but should be reported to a healthcare provider.

Stamaril should be handled and administered by a qualified healthcare professional. It is important to inform your provider of any allergies, especially to eggs or previous vaccines. Pregnant or breastfeeding individuals should consult a doctor before use. Keep the vaccine refrigerated until use and avoid freezing.

Stamaril may interact with immunosuppressive therapies, including corticosteroids or chemotherapy, potentially reducing its effectiveness. Avoid receiving other live vaccines within 30 days unless directed by a healthcare provider. Inform your doctor of all medications and conditions before vaccination.